Dave Skibinski is the president and CEO of SnapMD. Dave has been in the healthcare industry for over 25 years and brings a proven record of success in the enterprise software and Internet / e-commerce business sectors. Dave has worked in the healthcare field across every sales and service channel in the industry including children’s hospitals, cancer centers, teaching institutions, and government healthcare care at the federal, state and local levels. His time in the industry spans the earliest days of capitation and risk sharing contracts to the formation of today’s Accountable Care Organizations. He is known for his expert knowledge of healthcare systems and his skills in market analysis and strategy development.
Dave is a serial entrepreneur and has founded and worked in over a dozen startups; including being co-founder of QuantumMethod, a marketing and communications company with a significant book of work in the life sciences. For over a dozen years, he has been a consultant to numerous startups assisting them with sales and marketing plans, business strategy, and preparing business plans, financial models and investor pitch materials, and helped companies raise over $75 million in funding. He has also consulted with a variety of life science companies to evaluate new product feasibility, create commercialization strategies, and license intellectual property.
In addition to his BS in Biology from Indiana University, Dave holds an MBA from the University of Southern California.
Next-gen telemedicine platforms can help providers better serve their diabetic patients by enabling care to be delivered via on-demand and scheduled visits, providing increased access to convenient care.
Cloud-based platforms for telehealth eliminate the heavy burden of maintaining a locally installed native system while delivering all the benefits and security of cloud computing.
Join us on February 26 at 3 pm ET, and we’ll dive into the key areas where practices are losing time and money and provide solutions to overcome them.
The increasing competition between vendors suggests a civil war could be brewing in the American telemedicine industry.